Published in

American Society of Hematology, Blood, 4(131), p. 417-420

DOI: 10.1182/blood-2017-07-797019

Links

Tools

Export citation

Search in Google Scholar

Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network

Journal article published in 2017 by Sietse M. Aukema ORCID, Eva Hoster, Andreas Rosenwald, Danielle Canoni, Marie-Hélène Delfau-Larue, Grzegorz Rymkiewicz ORCID, Christoph Thorns, Sylvia Hartmann, Hanneke Kluin-Nelemans, Olivier Hermine, Martin Dreyling, Wolfram Klapper ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Key Points TP53 expression (>50% positive cells) has shorter TTF and poor OS independent of both MIPI score and Ki67 index.